Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 557,000 | 1,045,000 | 1,277,000 | 1,239,000 | 372,000 |
| Marketable Securities | N/A | N/A | 106,000 | 76,000 | 106,000 |
| Receivables | 181,000 | 180,000 | 169,000 | 180,000 | 231,000 |
| Inventories | 65,000 | 105,000 | 125,000 | 130,000 | 121,000 |
| Income taxes - deferred | N/A | 4,000 | 12,000 | 12,000 | 12,000 |
| Other current assets | 2,766,000 | 2,246,000 | 1,328,000 | 1,293,000 | 1,402,000 |
| TOTAL | $3,569,000 | $3,580,000 | $3,017,000 | $2,930,000 | $2,244,000 |
| Non-Current Assets | |||||
| PPE Net | 2,821,000 | 6,178,000 | 6,201,000 | 6,215,000 | 6,273,000 |
| Intangibles | 92,000 | 104,000 | 116,000 | 129,000 | 141,000 |
| Other Non-Current Assets | 1,829,000 | 1,244,000 | 529,000 | 545,000 | 1,355,000 |
| TOTAL | $4,742,000 | $7,526,000 | $6,846,000 | $6,889,000 | $7,769,000 |
| Total Assets | $8,311,000 | $11,106,000 | $9,863,000 | $9,819,000 | $10,013,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,000 | 200,000 | N/A | N/A | 148,000 |
| Accounts payable and accrued liabilities | 127,000 | 166,000 | 111,000 | 128,000 | 134,000 |
| Accrued Expenses | 65,000 | 213,000 | 137,000 | 197,000 | 145,000 |
| TOTAL | $3,051,000 | $6,035,000 | $2,299,000 | $2,492,000 | $1,565,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,069,000 | 1,656,000 | 4,052,000 | 3,621,000 | 4,626,000 |
| Other Non-Current Liabilities | 4,159,000 | 474,000 | 444,000 | 451,000 | 435,000 |
| TOTAL | $5,228,000 | $2,584,000 | $5,005,000 | $4,656,000 | $5,702,000 |
| Total Liabilities | $8,279,000 | $8,619,000 | $7,304,000 | $7,148,000 | $7,267,000 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | -4,258,000 | -3,464,000 | -3,389,000 | -3,273,000 | -3,196,000 |
| Other shareholders' equity | 4,290,000 | -52,000 | -53,000 | -54,000 | -55,000 |
| TOTAL | $32,000 | $2,487,000 | $2,559,000 | $2,671,000 | $2,746,000 |
| Total Liabilities And Equity | $8,311,000 | $11,106,000 | $9,863,000 | $9,819,000 | $10,013,000 |